New weight loss pill could replace needles: early safety trial begins

NCT ID NCT07388667

First seen Feb 05, 2026 · Last updated May 16, 2026 · Updated 10 times

Summary

This early-stage study is testing a new weight loss medicine called MK-4082, taken as a pill rather than an injection. Researchers want to see if it is safe and how the body handles different doses. The study involves 120 healthy adults with a body mass index (BMI) between 25 and 40. This is a first step to find a safe dose for future studies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Anaheim Clinical Trials ( Site 0005)

    RECRUITING

    Anaheim, California, 92801, United States

    Contact Phone: •••-•••-••••

  • Bio-Kinetic Clinical Applications, LLD dba QPS-MO ( Site 0004)

    ACTIVE_NOT_RECRUITING

    Springfield, Missouri, 65802, United States

  • Hassman Research Institute Marlton Site ( Site 0006)

    RECRUITING

    Marlton, New Jersey, 08053, United States

    Contact Phone: •••-•••-••••

  • ProSciento Inc. ( Site 0002)

    RECRUITING

    Chula Vista, California, 91911, United States

    Contact Phone: •••-•••-••••

  • QPS-MRA, LLC ( Site 0003)

    RECRUITING

    South Miami, Florida, 33143, United States

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.